2025
SJR Q2
JCR Q2 · 3
20 eşleşen makale
SCIE
Dergi ayrıntısı
Journal of Gene Medicine
- Yayıncı
- John Wiley and Sons Ltd
- Ülke
- United States · Northern America
- Tür
- journal
- ISSN
-
1099498X15212254
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR 0,746
- Quartile Q2
- H-Index 104
- Atıf/yayın 2,89
- Doküman (3y) 323
- Atıf (3y) 925
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 3
- 5Y JIF 2,7
- JCI 0,62
WoS indeksleri
- SCIE
Konu sınıflandırması
Kategoriler (SJR)
- Drug Discovery Q2
- Genetics Q2
- Genetics (clinical) Q2
- Molecular Biology Q3
- Molecular Medicine Q3
Alanlar
- Biochemistry, Genetics and Molecular Biology
- Medicine
- Pharmacology, Toxicology and Pharmaceutics
WoS kategorileri
- Biotechnology & Applied Microbiology | Genetics & Heredity | Medicine, Research & Experimental
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q2 | 0,746 | 3 | 2,7 | 0,62 | Q2 | 104 |
| 2024 | Q2 | Q3 | 0,712 | 2,2 | 2,3 | 0,68 | Q2 | 102 |
| 2023 | Q2 | Q2 | 0,679 | 3,2 | 3,1 | 0,76 | Q2 | 102 |
| 2022 | Q2 | Q2 | 0,657 | 3,5 | 3,4 | 0,78 | Q2 | 102 |
| 2021 | Q2 | Q2 | 0,62 | 4,2 | 3,8 | 0,72 | Q2 | 102 |
| 2020 | Q2 | Q2 | 0,689 | 4,6 | 3,3 | 0,73 | Q2 | 102 |
| 2019 | Q2 | Q2 | 0,585 | 3,3 | 2,5 | 0,68 | Q2 | 102 |
| 2018 | — | Q4 | — | 1,6 | 2,1 | 0,52 | Q3 | — |
| 2017 | Q3 | Q3 | 0,493 | 1,6 | 2,2 | 0,55 | Q3 | 102 |
| 2016 | Q1 | Q2 | 1,146 | 2,5 | 2,3 | — | — | 102 |
| 2015 | Q1 | Q2 | 1,05 | 3,2 | 2,1 | — | — | 102 |
| 2014 | Q2 | Q2 | 0,808 | 2,5 | 2,2 | — | — | 102 |
| 2013 | Q2 | Q3 | 0,842 | 2 | 2,1 | — | — | 102 |
| 2012 | Q2 | Q2 | 0,841 | 2,2 | 2,5 | — | — | 102 |
| 2011 | Q2 | Q2 | 0,891 | 2,5 | 2,6 | — | — | 102 |
| 2010 | Q1 | Q2 | 0,991 | 3,1 | 3,2 | — | — | 102 |
| 2009 | — | Q2 | — | 3 | 3,3 | — | — | — |
| 2008 | — | Q1 | — | 3,1 | 3,4 | — | — | — |
| 2007 | — | Q1 | — | 3,5 | 3,7 | — | — | — |
| 2006 | — | Q1 | — | 3,9 | — | — | — | — |
| 2005 | — | Q1 | — | 3,7 | — | — | — | — |
| 2004 | — | Q1 | — | 3,2 | — | — | — | — |
| 2003 | — | Q1 | — | 3,8 | — | — | — | — |
| 2002 | — | Q1 | — | 4,6 | — | — | — | — |
| 2001 | — | Q1 | — | 4,8 | — | — | — | — |
| 2000 | — | Q1 | — | 3,1 | — | — | — | — |
| 1999 | — | — | — | — | — | — | — | — |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2025 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q3 | Q3 | 102/180 |
| 2025 | GENETICS & HEREDITY | SCIE | Q2 | Q3 | 80/192 |
| 2025 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q2 | 96/191 |
| 2024 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q3 | Q2 | 116/177 |
| 2024 | GENETICS & HEREDITY | SCIE | Q3 | Q2 | 110/192 |
| 2024 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q2 | 109/195 |
| 2023 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | Q2 | 75/174 |
| 2023 | GENETICS & HEREDITY | SCIE | Q2 | Q2 | 69/191 |
| 2023 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q2 | 81/189 |
| 2022 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | Q2 | 69/158 |
| 2022 | GENETICS & HEREDITY | SCIE | Q2 | Q2 | 66/171 |
| 2022 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q2 | 76/136 |
| 2021 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | Q2 | 64/159 |
| 2021 | GENETICS & HEREDITY | SCIE | Q2 | Q2 | 71/175 |
| 2021 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q2 | 74/139 |
| 2020 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | Q2 | 43/159 |
| 2020 | GENETICS & HEREDITY | SCIE | Q2 | Q3 | 50/176 |
| 2020 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q2 | 60/140 |
| 2019 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | Q2 | 57/156 |
| 2019 | GENETICS & HEREDITY | SCIE | Q2 | Q3 | 76/178 |
| 2019 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q3 | 66/139 |
| 2018 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q4 | Q3 | 124/162 |
| 2018 | GENETICS & HEREDITY | SCIE | Q4 | Q3 | 135/174 |
| 2018 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | Q3 | 106/136 |
| 2017 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q3 | Q3 | 111/161 |
| 2017 | GENETICS & HEREDITY | SCIE | Q4 | Q3 | 130/171 |
| 2017 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | Q3 | 101/133 |
| 2016 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | — | 63/160 |
| 2016 | GENETICS & HEREDITY | SCIE | Q2 | — | 80/167 |
| 2016 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 63/128 |
| 2015 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | — | 43/161 |
| 2015 | GENETICS & HEREDITY | SCIE | Q2 | — | 59/166 |
| 2015 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 38/124 |
| 2014 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | — | 62/163 |
| 2014 | GENETICS & HEREDITY | SCIE | Q3 | — | 85/167 |
| 2014 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 61/123 |
| 2013 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q3 | — | 86/165 |
| 2013 | GENETICS & HEREDITY | SCIE | Q3 | — | 112/165 |
| 2013 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 73/124 |
| 2012 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | — | 78/160 |
| 2012 | GENETICS & HEREDITY | SCIE | Q3 | — | 101/161 |
| 2012 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 65/121 |
| 2011 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | — | 63/158 |
| 2011 | GENETICS & HEREDITY | SCIE | Q3 | — | 83/158 |
| 2011 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 50/112 |
| 2010 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | — | 44/160 |
| 2010 | GENETICS & HEREDITY | SCIE | Q2 | — | 63/156 |
| 2010 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 32/106 |
| 2009 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | — | 44/152 |
| 2009 | GENETICS & HEREDITY | SCIE | Q2 | — | 63/146 |
| 2009 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 29/93 |
| 2008 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 33/144 |
| 2008 | GENETICS & HEREDITY | SCIE | Q2 | — | 56/138 |
| 2008 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 23/83 |
| 2007 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 27/138 |
| 2007 | GENETICS & HEREDITY | SCIE | Q2 | — | 48/132 |
| 2007 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 18/81 |
| 2006 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 22/140 |
| 2006 | GENETICS & HEREDITY | SCIE | Q2 | — | 39/131 |
| 2006 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 15/76 |
| 2005 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 22/139 |
| 2005 | GENETICS & HEREDITY | SCIE | Q2 | — | 35/124 |
| 2005 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 13/72 |
| 2004 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 26/133 |
| 2004 | GENETICS & HEREDITY | SCIE | Q2 | — | 39/120 |
| 2004 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 15/71 |
| 2003 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 16/132 |
| 2003 | GENETICS & HEREDITY | SCIE | Q1 | — | 30/120 |
| 2003 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 12/72 |
| 2002 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 11/131 |
| 2002 | GENETICS & HEREDITY | SCIE | Q1 | — | 22/115 |
| 2002 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 9/74 |
| 2001 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 9/131 |
| 2001 | GENETICS & HEREDITY | SCIE | Q1 | — | 19/113 |
| 2001 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 8/75 |
| 2000 | GENETICS & HEREDITY | SCIE | Q2 | — | 38/114 |
| 2000 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 14/74 |
| 1999 | GENETICS & HEREDITY | SCIE | — | — | — |
| 1999 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | — | — | — |